Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
22,951.60
(
0.00%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
103.31
(
2.62%
)
Bitcoin
68,534.98
(
-0.36%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122815
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ChikiTiny post# 207839

Tuesday, 01/10/2017 1:08:04 PM

Tuesday, January 10, 2017 1:08:04 PM

Post# of 257295

ENTA—...were the CERTAIN-1 study results released earlier than expected?

The original listing for the trial in clinicaltrials.gov showed primary-endpoint completion in May 2017, but at some point it was moved up to Dec 2016. So, the results from the 8-week TN/GT1 arm in yesterday's PR came out earlier than originally expected. Note, however, that ABBV/ENTA have not yet reported data from the 12-week arm for all genotypes or from the arm limited to renally-impaired patients.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today